{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:17Z","timestamp":1791412037348,"version":"4.3.3"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.autrev.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T21:17:00Z","timestamp":1460409420000},"page":"856-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Gerd","family":"Wallukat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.autrev.2016.04.005_bb0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.autrev.2016.04.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2016.04.005_bb0015","series-title":"The heart in rheumatologic, inflammatory and autoimmune diseases: pathophysiology, clinical aspects and therapeutic approaches","article-title":"Autoantibodies against G-protein-coupled receptors in cardiovascular diseases: basics and diagnostics","author":"Bornholz","year":"2016"},{"key":"10.1016\/j.autrev.2016.04.005_bb0020","series-title":"The heart in rheumatologic, inflammatory and autoimmune diseases: pathophysiology, clinical aspects and therapeutic approaches","article-title":"Autoantibody directed therapy in cardiovascular diseases","author":"M\u00fcller","year":"2016"},{"key":"10.1016\/j.autrev.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosissup.2015.02.023","article-title":"Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.","volume":"18","author":"Dandel","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.autrev.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosissup.2012.10.029","article-title":"Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.","volume":"14","author":"Dandel","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.autrev.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurjhf\/hfs123","article-title":"Long-term benefits of immunoadsorption in \u03b2(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.","volume":"14","author":"Dandel","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2016.04.005_bb0040","series-title":"Use of aptamers in therapy and\/or diagnosis of autoimmune diseases. EP2497828A1, WO2012119938A2, US9234201 B2","author":"Schimke","year":"2012"},{"key":"10.1016\/j.autrev.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2015.11.001","article-title":"Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: a vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.","volume":"244","author":"Wallukat","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2009.06.064","article-title":"Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients","volume":"55","author":"Wallukat","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1-2","key":"10.1016\/j.autrev.2016.04.005_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-014-2057-8","article-title":"Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats.","volume":"393","author":"Haberland","year":"2014","journal-title":"Mol Cell Biochem"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T08:25:06Z","timestamp":1536827106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721630091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S156899721630091X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.04.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}